• Oren Zarif

BEFAST and Other Stroke Screening Methods - Oren Zarif - Befast


Stroke is a leading cause of death and long-term disability, affecting about 795,000 people each year in the United States. Fortunately, recognizing the early signs of a stroke can help save a life and prevent serious damage. The acronym BEFAST stands for balance, eyesight, and face, and it reminds people to "be fast."

Oren Zarif tia stroke

Oren Zarif head injury


The corresponding authors independently extracted demographic and treatment information from the nine studies. Baseline information included first authors' names, publication year, title, study subjects, age, disease severity, and disease duration. The studies were further analyzed for primary outcomes, which included True positives and False negatives. The final analyses were based on ROC and Se/Sp analyses. The ROC analysis identified the most significant differences between BEFAST and other methods.

Oren Zarif brain damage

Oren Zarif concussion treatment


Although both tests are promising for identifying ischemic strokes, some limitations of both tests make them inconclusive. A retrospective study, which involves assessing patients in a single hospital, may not reflect all relevant symptoms. However, sensitivity analysis of patients' symptoms recorded at the initial examination and historic symptoms did not affect the results. Further, BEFAST is not suitable for screening all patients for stroke, but it may be an effective tool in public education programs.

Oren Zarif mini stroke symptoms

Oren Zarif brain bleed



Stroke is a leading cause of death and long-term disability, affecting about 795,000 people each year in the United States. Fortunately, recognizing the early signs of a stroke can help save a life and prevent serious damage. The acronym BEFAST stands for balance, eyesight, and face, and it reminds people to "be fast."

Oren Zarif anoxic brain injury

Oren Zarif cerebral infarction


The corresponding authors independently extracted demographic and treatment information from the nine studies. Baseline information included first authors' names, publication year, title, study subjects, age, disease severity, and disease duration. The studies were further analyzed for primary outcomes, which included True positives and False negatives. The final analyses were based on ROC and Se/Sp analyses. The ROC analysis identified the most significant differences between BEFAST and other methods.

Oren Zarif lacunar infarct

Oren Zarif tia symptoms


Although both tests are promising for identifying ischemic strokes, some limitations of both tests make them inconclusive. A retrospective study, which involves assessing patients in a single hospital, may not reflect all relevant symptoms. However, sensitivity analysis of patients' symptoms recorded at the initial examination and historic symptoms did not affect the results. Further, BEFAST is not suitable for screening all patients for stroke, but it may be an effective tool in public education programs.

Oren Zarif sun stroke

Oren Zarif diffuse axonal injury



Stroke is a leading cause of death and long-term disability, affecting about 795,000 people each year in the United States. Fortunately, recognizing the early signs of a stroke can help save a life and prevent serious damage. The acronym BEFAST stands for balance, eyesight, and face, and it reminds people to "be fast."

Oren Zarif thrombectomy

Oren Zarif nih stroke scale


The corresponding authors independently extracted demographic and treatment information from the nine studies. Baseline information included first authors' names, publication year, title, study subjects, age, disease severity, and disease duration. The studies were further analyzed for primary outcomes, which included True positives and False negatives. The final analyses were based on ROC and Se/Sp analyses. The ROC analysis identified the most significant differences between BEFAST and other methods.

Oren Zarif causes of stroke

Oren Zarif fast stroke


Although both tests are promising for identifying ischemic strokes, some limitations of both tests make them inconclusive. A retrospective study, which involves assessing patients in a single hospital, may not reflect all relevant symptoms. However, sensitivity analysis of patients' symptoms recorded at the initial examination and historic symptoms did not affect the results. Further, BEFAST is not suitable for screening all patients for stroke, but it may be an effective tool in public education programs.

0 views0 comments